Month: April 2018

Macrophage Pharma Appoints Dr Michael Moore as Chairman

11 April 2018, Windsor, UK: Macrophage Pharma Limited (‘MPL’), a company focused on the discovery and development of next-generation small molecules aiming to modulate immune responses to combat cancer and other diseases, announced today that it has appointed Dr. Michael Moore as non-executive Chairman with immediate effect. Commenting on the appointment, Steven Powell, CEO of … Continue reading “Macrophage Pharma Appoints Dr Michael Moore as Chairman”